Miscellaneous ePI Test
0.1.0 - CI Build
Miscellaneous ePI Test
0.1.0 - CI Build
Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define constraints on FHIR data types for systems conforming to this implementation guide.
| HtmlElementLink | |
| HtmlElementLinkV3 | |
| Lenses |
Conveying Lens Information in the FHIR format |
These define sets of codes used by systems conforming to this implementation guide.
| DLCategoryVS |
| PDcategoryVS |
| PDtypeVS |
These define new code systems used by systems conforming to this implementation guide.
| Category of EPI |
Category of EPI |
| Example ICPC2 CS |
Example ICPC2 CS |
| Persona Vector Dimensions Code |
Persona Vector Dimensions Code |
| Persona Vector Dimensions categories |
Persona Vector Dimensions categories |
| Questionnaire example Dimensions |
Questionnaire example Dimensions |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| 0818 create organization |
Add organization description here |
| 28 tablets in bottle |
28 tablets in bottle |
| Add title here |
Add description here |
| Administrable Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
Administrable Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
| Administrable Product - Tegretol (carbamazepine) 200 mg for tablet |
Administrable Product - Tegretol (carbamazepine) 200 mg for tablet |
| Administrable Product - simvastatin 20 mg tablet |
Administrable Product - simvastatin 20 mg tablet |
| BeneFIX SmPC Belgium |
BeneFIX 250, 500, 1000 & 2000 IU - SUMMARY OF PRODUCT CHARACTERISTICS - Belgium |
| BenefiX SmPC Bundle |
Bundle of BenefiX SmPC |
| Bundle Japan JA - Package Insert for Herceptin (trastazumab) 150 mg for Intravenous Use |
Bundle Japan JA - Package Insert for Herceptin (trastazumab) 150 mg for Intravenous Use |
| Bundle Japan JA - Package Insert for Simvastatin 20 mg tablets |
Bundle Japan JA - Package Insert for Simvastatin 20 mg tablets |
| Bundle Japan JA - Package Insert for Tegretol (carbamazepine) 200 mg for tablet |
Bundle Japan JA - Package Insert for Tegretol (carbamazepine) 200 mg for tablet |
| Bundle Jordan AR - Package Leaflet for zithromax (azithromycin) 250 mg capsules - zithromax (azithromycin) 250 mg capsules |
Bundle Jordan AR - Package Leaflet for zithromax (azithromycin) 250 mg capsules - zithromax (azithromycin) 250 mg capsules |
| Bundle Jordan AR - Patient Information for Talzenna 0.25 mg, 1 mg capsules |
Bundle Jordan AR - Patient Information for Talzenna 0.25 mg, 1 mg capsules |
| Bundle Jordan AR - Patient Medication Information for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
Bundle Jordan AR - Patient Medication Information for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
| Bundle Jordan EN - Product Monograph for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
Bundle Jordan EN - Product Monograph for Xyntha® Lyophilized Powder for Reconstitution in a Vial |
| Bundle PLD Palbociclib |
Bundle PLD Palbociclib |
| Bundle PLD Palbociclib Ibrance MYS Malay |
Bundle PLD Palbociclib Ibrance MYS Malay |
| Bundle for Enbrel 25mg PFS - Jordanian AR Package Leaflet |
Bundle for Enbrel (Etanercept) 25 mg solution for injection in pre-filled syringe - Jordanian AR Package Leaflet |
| Bundle for Enbrel 25mg PFS - Jordanian EN Package Leaflet |
Bundle for Enbrel (Etanercept) 25 mg solution for injection in pre-filled syringe - Jordanian EN Package Leaflet |
| Bundle for Enbrel 50mg PFP - Jordanian AR Package Leaflet |
Bundle for Enbrel (Etanercept) 50 mg solution for injection in pre-filled pen - Jordanian AR Package Leaflet |
| Bundle for Enbrel 50mg PFP - Jordanian EN Package Leaflet |
Bundle for Enbrel (Etanercept) 50 mg solution for injection in pre-filled pen - Jordanian EN Package Leaflet |
| Bundle for Enbrel 50mg PFS - Jordanian AR Package Leaflet |
Bundle for Enbrel (Etanercept) 50 mg solution for injection in pre-filled syringe - Jordanian AR Package Leaflet |
| Bundle for Enbrel 50mg PFS - Jordanian EN Package Leaflet |
Bundle for Enbrel (Etanercept) 50 mg solution for injection in pre-filled syringe - Jordanian EN Package Leaflet |
| Bundle for Genotropin 5.0/5.3/12 mg powder and solvent - AR Jordanian Package Leaflet |
Genotropin (Somatropin) 5.0/5.3/12 mg powder and solvent for solution for injection - AR Jordanian Package Leaflet |
| Bundle for Genotropin 5.0/5.3/12 mg powder and solvent - EN Jordanian Package Leaflet |
Genotropin (Somatropin) 5.0/5.3/12 mg powder and solvent for solution for injection - EN Jordanian Package Leaflet |
| Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian AR Package Leaflet |
Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian AR Package Leaflet |
| Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian EN Package Leaflet |
Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian EN Package Leaflet |
| Bundle for zithromax (azithromycin) POS - Jordanian AR Package Leaflet |
Bundle for zithromax (azithromycin) 200 mg/5 ml powder for oral suspension - Jordanian AR Package Leaflet |
| Bundle for zithromax (azithromycin) POS - Jordanian EN Package Leaflet |
Bundle for zithromax (azithromycin) 200 mg/5 ml powder for oral suspension - Jordanian EN Package Leaflet |
| CLDTemplate |
CLDTemplate |
| Composition - Patient Medicination Information : Xyntha® Lyophilized Powder for Reconstitution in a Vial |
Composition - Patient Medicination Information : Xyntha® Lyophilized Powder for Reconstitution in a Vial |
| Composition - Product Monograph for Package leaflet: Xyntha® Lyophilized Powder for Reconstitution in a Vial |
Composition - Product Monograph for Package leaflet: Xyntha® Lyophilized Powder for Reconstitution in a Vial |
| Composition PLD Palbociclib Ibrance MYS Malay |
Composition PLD Palbociclib Ibrance MYS Malay |
| Composition for Package leaflet: Arab Gulf and Jordan Talzenna 0.25 mg, 1 mg capsules |
Composition for Package leaflet: Arab Gulf and Jordan Talzenna 0.25 mg, 1 mg capsules |
| Herceptin (trastazumab) Package Leaflet - 150 mg for Intravenous Use |
Herceptin (trastazumab) Package Leaflet - 150 mg for Intravenous Use |
| Ibrance CLD Composition English |
Ibrance MYS CLD Composition in English |
| Ibrance CLD MYS Bundle English |
Ibrance CLD MYS Bundle English in English |
| Ibrance MAH |
Manufacturing address of Ibrance MYS |
| Ingredient - carbamazepine |
Ingredient - carbamazepine |
| Ingredient - simvastatin |
Ingredient - simvastatin |
| Ingredient - trastazumab |
Ingredient - trastazumab |
| Manufactured, Packaged and Released By Wyeth Farma S.A |
Manufactured, Packaged and Released By Wyeth Farma S.A |
| Marketing Authorization Holder - Chugai Pharmaceutical Co., Ltd. |
Marketing Authorization Holder - Chugai Pharmaceutical Co., Ltd. |
| Marketing Authorization Holder - Fujinaga Pharmaceutical Co., Ltd. |
Marketing Authorization Holder - Fujinaga Pharmaceutical Co., Ltd. |
| Marketing Authorization Holder - Ohara Pharmaceutical Co., Ltd. |
Marketing Authorization Holder - Ohara Pharmaceutical Co., Ltd. |
| Marketing authorisation holder - Pfizer Canada ULC. |
Pfizer Limited as Marketing authorisation holder |
| Master Gulf and Levant- Prevenar 13 0.5 ml- PLD Jordan |
Test for create Prevenar |
| Medicinal Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
Medicinal Product - Herceptin (trastazumab) 150 mg for Intravenous Use |
| Medicinal Product - Simvastatin 20 mg tablets |
Medicinal Product - Simvastatin 20 mg tablets |
| Medicinal Product - Tegretol (carbamazepine) 200 mg for tablet |
Medicinal Product - Tegretol (carbamazepine) 200 mg for tablet |
| Medicinal Product Enbrel 25mg PFS |
Enbrel 25 mg solution for injection in pre-filled syringe |
| Medicinal Product Enbrel 25mg PFS |
Enbrel 25 mg solution for injection in pre-filled syringe |
| Medicinal Product Enbrel 50mg PFP |
Enbrel 50 mg solution for injection in pre-filled pen |
| Medicinal Product Enbrel 50mg PFP |
Enbrel 50 mg solution for injection in pre-filled pen |
| Medicinal Product Enbrel 50mg PFS |
Enbrel 50 mg solution for injection in pre-filled syringe |
| Medicinal Product Enbrel 50mg PFS |
Enbrel 50 mg solution for injection in pre-filled syringe |
| Medicinal Product Genotropin 5.0/5.3/12 mg powder and solvent |
Genotropin 5.0/5.3/12 mg powder and solvent for solution for injection |
| Medicinal Product Genotropin 5.0/5.3/12 mg powder and solvent |
Genotropin 5.0/5.3/12 mg powder and solvent for solution for injection |
| Medicinal Product zithromax (azithromycin) 250 mg capsules |
zithromax (azithromycin) 250 mg capsules |
| Medicinal Product zithromax (azithromycin) 250 mg capsules |
zithromax (azithromycin) 250 mg capsules |
| Medicinal Product zithromax (azithromycin) 250 mg capsules - النشرة الداخلية: معلومات للمريض - كبسولات زيثروماكس® 250 مجم |
zithromax (azithromycin) 250 mg capsules - النشرة الداخلية: معلومات للمريض - كبسولات زيثروماكس® 250 مجم |
| Medicinal Product zithromax (azithromycin) 250 mg capsules - AR |
zithromax (azithromycin) 250 mg capsules - AR |
| Medicinal Product zithromax (azithromycin) POS |
zithromax (azithromycin) 200 mg/5 ml powder for oral suspension |
| Medicinal Product zithromax (azithromycin) POS |
zithromax (azithromycin) 200 mg/5 ml powder for oral suspension -أزيثرومايسين مسحوق 200 مغ/5 مل لتحضير معلق للاستعمال عبر الفم |
| Organization PLD Palbociclib Ibrance MYS Malay |
Organization PLD Palbociclib Ibrance MYS Malay |
| Organization_PLD_Palbociclib |
Organization_PLD_Palbociclib |
| PLD Palbociclib - Ibrance MYS English |
PLD Palbociclib - Ibrance MYS English |
| Package Leaflet - simvastatin 20 mg tablets |
Package Leaflet - simvastatin 20 mg tablets |
| Pfizer Europe MA EEIG |
MAH of BenefiX- Pfizer Europe MA EEIG |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer Limited as Marketing authorisation holder |
Pfizer Limited as Marketing authorisation holder |
| Pfizer Limited as Marketing authorisation holder |
Pfizer Limited as Marketing authorisation holder |
| Pfizer Limited as Marketing authorisation holder |
Pfizer Limited as Marketing authorisation holder |
| Pfizer Limited as Marketing authorisation holder |
Pfizer Limited as Marketing authorisation holder |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom |
| Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom - AR |
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom - AR |
| Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
Pfizer SA, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium |
| Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
| Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use |
| Regulated Authorization - Tegretol (carbamazepine) 200 mg for tablet |
Regulated Authorization - Tegretol (carbamazepine) 200 mg for tablet |
| SmPCtemplate |
SmPCtemplate |
| Substance - simvastatin |
Substance - simvastatin |
| Substance - trastazumab |
Substance - trastazumab |
| Substance - trastazumab |
Substance - trastazumab |
| TSZ 0817 Organization creation |
test of organization creation |
| TSZ 0818 Bundle UK EN - PIL Talzenna |
test bundle creation |
| TSZ 0818TestandLearn Composition |
0818TestandLearn Description |
| Tegretol (carbamazepine) 200 mg for tablet |
Tegretol (carbamazepine) 200 mg for tablet |
| Template of Bundle |
Create Bundle template for debug |
| Template of CLD Bundle |
Create CLD Bundle template for debug Oct30 |
| Template of organization |
Create template for debug |
| Test for compostion template |
Add description here |
| binaryimage0014 |
clip_image014_-861669482.jpg |
| binaryimage003 |
clip_image003_-1584181510.png |
| binaryimage003-1537998405 |
image003_1537998405 |
| binaryimage004 |
clip_image004_128978964.png |
| binaryimage004-124372563 |
binaryimage004_124372563 |
| binaryimage006 |
clip_image006_1402751276.png |
| binaryimage006-1085115419 |
binaryimage006_1085115419 |
| binaryimage007 |
clip_image007_1848870172.png |
| binaryimage007-1887834135 |
binaryimage007_1887834135 |
| binaryimage008 |
clip_image008_-1930407291.png |
| binaryimage008-1358253692 |
binaryimage008_1358253692 |
| binaryimage010 |
clip_image010_524367703.png |
| binaryimage010-240412440 |
binaryimage010_240412440 |
| binaryimage012-1035983834 |
binaryimage012_1035983834 |
| binaryimage012-251481591 |
binaryimage012_251481591 |
| binaryimage012a |
clip_image012_583978923.png |
| binaryimage012b |
clip_image012_-1646958650.png |
| binaryimage013 |
clip_image013_1472120925.png |
| binaryimage013-244659630 |
binaryimage013_244659630 |
| binaryimage014-39753133 |
binaryimage014_39753133 |
| binaryimage016-646543884 |
binaryimage016_646543884 |
| binarypfizerlogo |
Pfizer Logo |
| bundle for prevenar |
bundle for prevenar |
| carnubawax |
Carnauba wax |
| crystallinecellulose |
crystalline cellulose |
| ePI document Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian Package Leaflet |
Bundle for zithromax (azithromycin) 250 mg capsules - Jordanian Package Leaflet |
| hypromelose |
HYPROMELLOSE, UNSPECIFIED |
| lightanhydroussilicicacid |
light anhydrous silicic acid |
| magnesiumcarbonate |
MAGNESIUM CARBONATE |
| magnesiumstearate |
MAGNESIUM STEARATE |
| manitemcarbamazepine200 |
Manufactured Item - Tegretol (carbamazepine) 200 mg for tablet |
| manitemherceptin150 |
Manufactured Item - Herceptin (trastazumab) 150 mg for Intravenous Use |
| manitemsimvastatin20 |
Manufactured Item - Simvastatin 20 mg tablets |
| mannitol |
MANNITOL |
| methylparaben |
METHYLPARABEN |
| org for Master Gulf and Levant- Prevenar 13--0.5 ml- PLD Jordan |
org for Master Gulf and Levant- Prevenar 13–0.5 ml- PLD Jordan |
| packherceptinvial |
28 tablets |
| packsimvastatin20 |
28 tablets |
| polyethyleneglycol |
POLYETHYLENE GLYCOL 6000 |
| polysorbate |
POLYSORBATE 80 |
| polyvinylalcohol |
POLYVINYL ALCOHOL, UNSPECIFIED |
| silicondioxide |
SILICON DIOXIDE |
| sodiumstarch |
SODIUM STARCH GLYCOLATE TYPE A POTATO |
| sucrose |
SUCROSE |
| syntehticwax |
synthetic wax |
| talc |
talc |
| titaniumdioxide2 |
TITANIUM DIOXIDE |
These are resources that are used within this implementation guide that do not fit into one of the other categories.
IG © 2022+ . Package hl7.fhir.uv.epi-test#0.1.0 based on FHIR 5.0.0. Generated 2024-04-04
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
